Xaliproden hydrochloride

Base Information

• Chemical Name: Xaliproden hydrochloride
• CAS No.: 90494-79-4
• Molecular Formula: C24H22F3N^.HCl
• Molecular Weight: 417.89
• European Community (EC) Number: 635-870-6
• UNII: 44D5EE8E26
• DSSTox Substance ID: DTXSID5046724
• Wikidata: Q27258737
• NCI Thesaurus Code: C61328
• ChEMBL ID: CHEMBL3183486
• Mol file: 90494-79-4.mol

Synonyms:1-(2-(naphth-2-yl)ethyl)-4-(3-trifluoromethylphenyl)-1,2,5,6-tetrahydropyridine hydrochloride;1-(2-(naphth-2-yl)ethyl)-4-(trifluoromethylphenyl)-1,2,5,6-tetrahydropyridine hydrochloride;SR 57746A;SR-57746A;SR57746A;xaliproden;xaliproden hydrochloride

Chemical Property of Xaliproden hydrochloride

Chemical Property:

• Vapor Pressure: 1.15E-09mmHg at 25°C
• Melting Point: 255-260°
• Boiling Point: 487.8 °C at 760 mmHg
• Flash Point: 248.8 °C
• PSA: 3.24000
• LogP: 6.93030
• Storage Temp.: 2-8°C
• Solubility.: DMSO: ≥5mg/mL
• Hydrogen Bond Donor Count: 1
• Hydrogen Bond Acceptor Count: 4
• Rotatable Bond Count: 4
• Exact Mass: 417.1471119
• Heavy Atom Count: 29
• Complexity: 541

Purity/Quality:

98% ^*data from raw suppliers

Xaliproden hydrochloride ^*data from reagent suppliers

Safty Information:

• Pictogram(s):  
• Hazard Codes: 

MSDS Files:

SDS file from LookChem

Useful:

• Canonical SMILES: C1CN(CC=C1C2=CC(=CC=C2)C(F)(F)F)CCC3=CC4=CC=CC=C4C=C3.Cl
• Recent EU Clinical Trials: A multicenter, randomized, double blind, placebo controlled Phase III study to assess the efficacy of xaliproden in patients with oxaliplatin-induced peripheral sensory neuropathy (PSN) following adjuvant chemotherapy for colon cancer